Published in Lancet on March 02, 2002
Complement factor H and the haemolytic uraemic syndrome. Lancet (2001) 1.74
Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes (2005) 1.75
Nephrin deficiency activates NF-kappaB and promotes glomerular injury. J Am Soc Nephrol (2009) 1.57
Mycophenolate mofetil for remission induction in severe lupus nephritis. Nephron Clin Pract (2005) 1.44
Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria. Kidney Int (2010) 1.22
Identification of the glomerular podocyte as a target for growth hormone action. Endocrinology (2007) 0.94
Is it intelligent to intercalate? A two centre cross-sectional study exploring the value of intercalated degrees, and the possible effects of the recent tuition fee rise in England. BMJ Open (2013) 0.94
PPARalpha activation upregulates nephrin expression in human embryonic kidney epithelial cells and podocytes by a dual mechanism. Biochem Biophys Res Commun (2005) 0.90
Hemolytic uremic syndrome in metastatic adenocarcinoma of the prostate. Am J Kidney Dis (2002) 0.89
Sirolimus toxicity and vascular endothelial growth factor release from islet and renal cell lines. Transplantation (2007) 0.87
A string of beads. Am J Med (2008) 0.86
Phenotypic expression of ADAMTS13 in glomerular endothelial cells. PLoS One (2011) 0.86
Null mutations at the p66 and bradykinin 2 receptor loci induce divergent phenotypes in the diabetic kidney. Am J Physiol Renal Physiol (2012) 0.81
Human leukocyte antigen-specific antibodies and gamma-interferon stimulate human microvascular and glomerular endothelial cells to produce complement factor C4. Transplantation (2012) 0.80
Familial mesangio-capillary glomerulonephritis with initial presentation as haemolytic uraemic syndrome. Nephrol Dial Transplant (2004) 0.78
The NHS academic vision: training the physicians to deliver it. Clin Med (2011) 0.75